Frank Oaks

Dionex Corp. develops, manufactures, sells, and services chromatography and extraction systems for separating, isolating, and identifying the components of chemical mixtures. The firm's products are used extensively by the environmental, life science, pharmaceutical, food and beverage, chemicals, electronics and power industries. The company was founded in 1975 and is headquartered in Sunnyvale, CA.

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

Solarflare Communications, Inc. develops server networking solutions. Its products include app acceleration, server security, network capture and network adapters. The firm offers electronic trading, database caching, networked storage, server security, software load balancers and web server solutions. The company was founded by Derek Roberts, Ben Charny, David Riddoch, Ahmet Tuncay, George A. Zimmerman and Pope Steve in 2001 and is headquartered in Irvine, CA.

ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Amadeus Capital Partners Ltd is an independent venture capital firm is founded by Anne Glover and Hermann Hauser in 1997. The firm is headquartered in London, UK.

Part of ION Investment Group Ltd., Olivetti UK Ltd. is a company that specializes in the sale and maintenance of information processing systems, office products, and software. The company is based in Milton Keynes, UK.

Part of Liberty Global Ltd., NetChannel UK is a telecommunications company. NetChannel UK is based in London, UK. The British company was founded by Hermann Maria Hauser, Jean-Paul Stephen Rohan.

Part of Teledyne Technologies, Inc., Princeton Instruments supplies scientific instruments. The company is based in Lexington, MA. Princeton Instruments was acquired by Roper Technologies, Inc. on May 16, 1997 for $40.40 million.

Part of Agilisys Holdings Ltd., Vocalis Ltd. develops and markets speech recognition applications for telephone systems and computers. The company is based in Cambridge, UK. The British company was founded by Hermann Maria Hauser.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Cavendish Kinetics, Inc. provides radio frequency tuning solutions for mobile devices in the wireless industry. It is a fabless supplier of tunable components for RF circuits used in cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. The firm offers tunable RF circuits, based on third-generation RF MEMS technology and its semiconductor processes, let users pack more performance into the same space. The company was founded by Charles Gordon Smith and Hermann M. Hauser in 1994 and is headquartered in San Jose, CA.

XMOS Ltd. develops voice and music processing and control integrated circuits. Its products include voice controller solutions, audio connectivity, xCORE microcontrollers, and xTIMEcomposer tools. The company was founded by Hitesh Kumar Mehta, Dixon Ali, Noel Hurley, James Foster, and Michael David May on June 29, 2005 and is headquartered in Bristol, the United Kingdom.

Veebeam Corp. develops wireless technology and products. The company was founded in 2002 and is headquartered in Santa Clara, CA.

Amadeus Partners Ltd. provides security broking and fund management services. It specializes in activities of venture and development capital companies. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

FlexEnable Ltd. engages in the development and commercialization of organic electronics. Its services include material sales, technology transfer, technology licensing and product prototying. The company was founded by Richard Friend, Stuart McLellan Evans, and Henning Sirringhaus on January 11, 2000 and is headquartered in Cambridge, the United Kingdom.

Cambridge Network Ltd. operates as a membership organization. It bring people together to meet each other and share ideas, encouraging collaboration and partnership for shared success. The company was founded by Alec Broers, Hermann Hauser, David Cleevely, Nigel Brown, Fred Hallsworth, and Anthony Ross in 1998 and is headquartered in Cambridge, the United Kingdom.

Part of Thermo Fisher Scientific, Inc., Applied Biosystems LLC develops and markets instrument-based systems, consumables, software, and services for academic research, the life science industry, and commercial markets. The company is based in Wilmington, DE.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022.

Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope.